MedPath

Cephalon LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:10
NMPA:2

Drug Approvals

Bendamustine Hydrochloride for Injection

Product Name
存达
Approval Number
国药准字HJ20180087
Approval Date
Aug 1, 2023
NMPA

Bendamustine Hydrochloride for Injection

Product Name
存达
Approval Number
H20180087
Approval Date
Dec 17, 2018
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.